Cisplatin accord fachinfo

Author: uydr

August undefined, 2024

WebCisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg/mL and sodium chloride 9 mg/mL in water for injections. 4 CLINICAL PARTICULARS … WebJun 4, 2024 · heart problems--chest pain, irregular heartbeats, swelling in your lower legs, rapid weight gain, feeling lightheaded or short of breath; or low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.

Injectables Products - Accord Healthcare

WebPemetrexed Accord in combination with cisplatin The recommended dose of Pemetrexed Accord is 500 mg/m2 of body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle. The recommended dose of cisplatin is 75 mg/m2 BSA infused over two hours approximately 30 minutes after completion WebCisplatină Accord, 1 mg/ml, concentrat pentru soluţie perfuzabilă Producător: Substanță activa Clasa ATC Format concentrat pentru soluţie perfuzabilă Afecțiuni diverse tipuri de cancer Producător Accord Healthcare Limited Acțiune terapeutică citostatice Cuprins Ce este Cisplatină Accord şi pentru ce se utilizează irs2 compound name

Drug Shortage Detail: Cisplatin Injection - American Society of …

Web– Cisplatin wird angewendet in Kom-bination mit anderen Chemothera-peutika oder einer Strahlentherapie zur Behandlung des Zervixkarzinoms. – Cisplatin kann als Mono- oder Kombi nationstherapie angewendet werden. 4.2 Dosierung und Art der Anwendung Dosierung Erwachsene und Kinder: Die Cisplatindosis ist abhängig von Web/de/drugs/4LKkeHTvGRdBw2MF4IGVmoSGOy6/fluorouracil-accord-50-mg-ml-injektions-infusionslosung-20-ml WebA document describing the properties and the officially approved conditions of use of a medicine. Summaries of product characteristics form the basis of information for healthcare professionals on how to use the medicine safely and effectively. Abbreviated as SmPC. portal 2 coop levels

FACHINFORMATION Carboplatin 10 mg/ml Konzentrat zur

WebApr 12, 2024 · Accord has cisplatin 1 mg/mL 50 mL and 100 mL vials on back order and the company cannot estimate a release date. Fresenius Kabi has cisplatin 1 mg/mL 50 … WebCisplatin Accord 1 mg/1 mL is available as a 10 mg/10 mL, 25 mg/25 mL, 50 mg/50 mL and 100 mg/100 mL solution for injection. For the full list of excipients, see . Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM . Solution for injection . Cisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg ... irs.wa.gov official siteWebCisplatin is only given by injection into a vein (an intravenous infusion). Supportive equipment should be available to control anaphylactic reactions. Cisplatin should not come into contact with any materials that contain aluminium. The recommended dosage of Cisplatin depends on your well-being, the portal 2 desktop background

"WebNov 30, 2024 · If cisplatin is used in combination chemotherapy, the dose of cisplatin must be reduced. A typical dose is 20 mg/m 2 or more once every 3 to 4 weeks unless in the combination therapy of small-cell and non-small-cell lung carcinoma, in which a typical dose of 80 mg/m 2 is administered. " - Cisplatin accord fachinfo

Cisplatin accord fachinfo

Cisplatin 1mg/ml Injection BP - Summary of Product ... - medicines

WebJun 1, 2024 · A phase 2 trial of durvalumab in combination with gemcitabine and cisplatin demonstrated promising efficacy, with an objective response rate of 72% and a median overall survival of 20.2 months... WebCisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and/or radiotherapy. CONTRAINDICATIONS Cisplatin is contraindicated in patients with preexisting renal impairment.

Did you know?

WebCisplatina Accord 1 mg / ml x 1 flacon x 10 ml concentrat pentru solutie perfuzbila - Catena. Cisplatina apartine unui grup de medicamente cunoscute sub numele de citostatice, care sunt utilizate în tratamentul cancerului. Cisplatina poate fi utilizată singură, dar si in asociere cu alte citostatice. ...

WebCisplatin Accord® 10 mg/10 ml. Dosierung: 10 mg/10 ml. Darreichungsform: Durchstechflasche. Packungsgrösse: 1. Galenische Form: Konzentrat zur Herstellung … Webexperienced nephrotoxicity as a result of cisplatin therapy. The carcinogenic potential of carboplatin has not been studied but compounds with similar mechanisms of action and …

WebUnser Produktportfolio. Unser Portfolio umfasst zahlreiche Präparate aus verschiedensten Therapiegebieten wie etwa Onkologie & Hämatologie, Notfallmedizin, … WebCisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung. 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG. 1 ml des Konzentrats zur Herstellung einer Infusionslösung enthält 1 mg Cisplatin. 10 ml des Konzentrats zur Herstellung einer Infusionslösung enthalten 10 mg Cisplatin.

WebInjectables Products - Accord Healthcare Products Enhancing the pharmaceutical experience for providers and patients. Orals Injectables Topicals Rems Products All Products A B C D E F G H I J K L M N O P …

Web1. Mitä Cisplatin Accord 1 mg/ml on ja mihin sitä käytetään 2. Mitä sinun on tiedettävä, ennen kuin käytät Cisplatin Accord 1 mg/ml -valmistetta 3. Miten Cisplatin Accord 1 mg/ml -valmistetta käytetään 4. Mahdolliset haittavaikutukset 5. Cisplatin Accord 1 mg/ml -valmisteen säilyttäminen 6. Pakkauksen sisältö ja muuta tietoa 1. portal 2 end credit songWebPage 7/10 Safety Data Sheet acc. to OSHA HCS Printing date 09/09/2024 Revision date 09/09/2024 Trade name:Cisplatin (Contd. from page 6) 53.1.21 · Primary irritant effect: · on the skin:No irritant effect. · on the eye:Strong irritant with the danger of severe eye injury. · Sensitization: Sensitization possible through inhalation. irs/bondsWebFind details around Cisplatin from Accord-Healthcare: the evolution of generics. portal 2 for ps4Weboder bei mit Cisplatin vorbehandelten Patienten zu. Der Patient sollte neuro-logisch überwacht und in regelmä-ßigen Abständen neurologisch unter-sucht werden. Bei … irs4427 pricwWebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have … portal 2 fstop downloadWebCisplatin Accord 1 mg/ml konsentrat til infusjonsvæske UK/H/2862/001 08-6418 ACCORD HEALTHCARE LIMITED NO Cisplatina Accord 1 mg/ml concentrado para solução para … portal 2 heuftWebCisplatin Injection is a clear, colorless to pale yellow, sterile aqueous solution. Each 50 mL or 100 mL amber vial of Cisplatin Injection contains: 1 mg/mL cisplatin, 9 mg/mL … irsa archive